These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 27760780)
41. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
42. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. Hormozi K; Parton R; Coote J FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286 [TBL] [Abstract][Full Text] [Related]
43. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640 [TBL] [Abstract][Full Text] [Related]
44. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Guiso N; Rocancourt M; Szatanik M; Alonso JM Microb Pathog; 1989 Nov; 7(5):373-80. PubMed ID: 2622329 [TBL] [Abstract][Full Text] [Related]
45. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway. Aase A; Herstad TK; Merino S; Brandsdal KT; Berdal BP; Aleksandersen EM; Aaberge IS Clin Vaccine Immunol; 2007 Jul; 14(7):855-62. PubMed ID: 17507542 [TBL] [Abstract][Full Text] [Related]
46. Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin. Gonyar LA; Gray MC; Christianson GJ; Mehrad B; Hewlett EL Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396321 [TBL] [Abstract][Full Text] [Related]
48. Bioengineering of Ladant D Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260 [TBL] [Abstract][Full Text] [Related]
49. Molecular aspects of Bordetella pertussis pathogenesis. Locht C Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406 [TBL] [Abstract][Full Text] [Related]
50. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777 [TBL] [Abstract][Full Text] [Related]
51. Neutralizing antibodies to pertussis toxin in whooping cough. Granström M; Granström G; Gillenius P; Askelöf P J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752 [TBL] [Abstract][Full Text] [Related]
52. Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo. Wagner EK; Wang X; Bui A; Maynard JA Clin Vaccine Immunol; 2016 Nov; 23(11):851-862. PubMed ID: 27581436 [TBL] [Abstract][Full Text] [Related]
53. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Gonik B; Puder KS; Gonik N; Kruger M Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994 [TBL] [Abstract][Full Text] [Related]
54. Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis. Nguyen AW; Wagner EK; Posada L; Liu X; Connelly S; Papin JF; Wolf RF; Kaleko M; Maynard JA J Vet Med Sci; 2017 Jan; 79(1):60-64. PubMed ID: 27666464 [TBL] [Abstract][Full Text] [Related]
55. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka. Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894 [TBL] [Abstract][Full Text] [Related]
56. Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity. Khelef N; Gounon P; Guiso N Cell Microbiol; 2001 Nov; 3(11):721-30. PubMed ID: 11696032 [TBL] [Abstract][Full Text] [Related]
57. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory. Stenger RM; Smits M; Kuipers B; van Gaans-van den Brink J; Poelen M; Boog CJ; van Els CA Vaccine; 2010 Sep; 28(40):6637-46. PubMed ID: 20637762 [TBL] [Abstract][Full Text] [Related]
58. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Betsou F; Sebo P; Guiso N Infect Immun; 1995 Sep; 63(9):3309-15. PubMed ID: 7642260 [TBL] [Abstract][Full Text] [Related]